netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Sunitinib found 8 matches
Open monograph to display formulary status BNF Category
  Sunitinib  (Sutent®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
  Cytotoxic Drug Regorafenib  (Stivarga® ) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (January 2011): Bevacizumab and sunitinib: risk of osteonecrosis of the jaw (08.01.05)
link in drug section MHRA Drug Safety Update (January 2011): Bevacizumab and sunitinib: risk of osteonecrosis of the jaw (08.01.05)
link in drug section NICE TA169: Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (08.01.05)
link in drug section NICE TA179: Sunitinib for the treatment of gastrointestinal stromal tumours (08.01.05)
link in drug section NICE TA449 Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease (08.01.05)
link in drug section NICE TA449 Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease (08.01.05)


 
netFormulary